Evommune, Inc.
EVMN
$20.49
$0.301.49%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -75.99M | -68.87M | -61.32M | -64.76M | -78.58M |
| Total Depreciation and Amortization | 1.36M | 1.39M | 1.42M | 1.44M | 1.39M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.42M | -4.84M | -8.40M | -8.38M | 307.00K |
| Change in Net Operating Assets | -3.00M | -4.12M | -9.95M | -23.15M | -383.00K |
| Cash from Operations | -80.05M | -76.44M | -78.25M | -94.85M | -77.26M |
| Capital Expenditure | -318.00K | -235.00K | -131.00K | 0.00 | -18.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -213.85M | -115.07M | -25.36M | 7.83M | -123.00K |
| Cash from Investing | -214.17M | -115.31M | -25.49M | 7.83M | -141.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -464.00K | -531.00K | -584.00K | -562.00K | -515.00K |
| Issuance of Common Stock | 274.49M | 157.29M | 17.00K | 17.00K | 13.00K |
| Repurchase of Common Stock | -1.22M | -1.22M | -- | -- | -- |
| Issuance of Preferred Stock | 65.23M | 65.23M | 115.06M | 115.06M | 49.83M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -874.00K | -736.00K | -- |
| Cash from Financing | 338.03M | 220.76M | 113.62M | 113.78M | 49.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 43.82M | 29.02M | 9.88M | 26.76M | -28.08M |